This activity is expired and is no longer available for CME credit.


Examining the Pathophysiology of Retinal Vein Occlusion and the Potential Role of Anti-VEGF Agents

Author(s)/Faculty: Szilard Kiss, MD
Release Date: 12/27/2013Expiration Date: 12/26/2014
Credit Type: CMENumber of Credits: 0
Content Type: MultimediaProvider:
As we all know, Retinal Vein Occlusion is the second most common retinal vascular disease. In the United States, approximately 180,000 new RVOs occur every year...